Legal Opinion
Paula Kuyat v. BioMimetic Therapeutics, Inc.
Court of Appeals for the Sixth Circuit
Decided March 28, 2014No. 13-5602PublishedCited by 119 opinions
1Opinion of the Court
OPINION
ROGERS, Circuit Judge.
In this securities fraud action, the plaintiffs contend that BioMimetic Therapeutics, Inc. misled investors about Augment Bone Graft’s prospects for Federal Drug Administration (FDA) approval. According to the plaintiffs, the FDA privately communicated to BioMimetie that the FDA expected the device’s clinical trials to prove that Augment was effective based on an analysis of all of the study’s participants. The clinical trials did not achieve those results. But if BioMimetie removed from its analysis study participants that did not actually receive treatment, then…
2Cases cited8 opinions
- Tellabs, Inc. v. Makor Issues & Rights, Ltd.Supreme Court of the United States · 2007
- Sidney Morse v. R. Clayton McWhorterCourt of Appeals for the Sixth Circuit · 2002
- Leisure Caviar, LLC v. United States Fish & Wildlife ServiceCourt of Appeals for the Sixth Circuit · 2010
- In Re Worlds Of Wonder Securities LitigationCourt of Appeals for the Ninth Circuit · 1994
- Pr Diamonds, Inc. v. John P. ChandlerCourt of Appeals for the Sixth Circuit · 2004
3 more not listed; retrieve them via the Exa API.
3Cited by119 opinions
- Todd Bates v. Green Farms Condominium Ass'nCourt of Appeals for the Sixth Circuit · 2020
- Ansfield v. Omnicare, Inc. (In Re Omicare, Inc. Securities Litigation)Court of Appeals for the Sixth Circuit · 2014
- Beverly Swanigan v. FCACourt of Appeals for the Sixth Circuit · 2019
- Kevin Dougherty v. Esperion TherapeuticsCourt of Appeals for the Sixth Circuit · 2018
- Matanky v. Gen. Motors LLCDistrict Court, E.D. Michigan · 2019
114 more not listed; retrieve them via the Exa API.